EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    2.7.6.2 | Anemia, Hemolytic |
6251690 |
Additional data from two kindreds with genetically induced deficiencies of erythrocyte pyrimidine nucleotidase. |
unassigned |
0 |
| 2.7.6.2 | Thiamine Deficiency |
8619543 |
Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. |
unassigned |
0 |
| 2.7.6.2 | Anemia, Hemolytic |
10916681 |
Chronic non-spherocytic haemolytic anaemia due to congenital pyrimidine 5' nucleotidase deficiency: 25 years later. |
unassigned |
0 |
| 2.7.6.2 | Pneumonia, Pneumocystis |
15531210 |
Cloning of the Pneumocystis jirovecii trifunctional FAS gene and complementation of its DHPS activity in Escherichia coli. |
ongoing research |
2 |
| 2.7.6.2 | Pneumonia, Pneumocystis |
15531210 |
Cloning of the Pneumocystis jirovecii trifunctional FAS gene and complementation of its DHPS activity in Escherichia coli. |
unassigned |
0 |
| 2.7.6.2 | Cardiotoxicity |
25316705 |
Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity. |
therapeutic application |
1 |
| 2.7.6.2 | Cardiotoxicity |
25316705 |
Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity. |
ongoing research |
2 |
| 2.7.6.2 | Cardiotoxicity |
25316705 |
Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity. |
unassigned |
0 |
| 2.7.6.2 | Nervous System Diseases |
25458521 |
Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. |
causal interaction |
4 |
| 2.7.6.2 | Nervous System Diseases |
25458521 |
Expanding the clinical and molecular spectrum of thiamine pyrophosphokinase deficiency: a treatable neurological disorder caused by TPK1 mutations. |
therapeutic application |
1 |
